Replies to post #343825 on NorthWest Biotherapeutics Inc (NWBO)

[erik007tc]

I agree wholeheartedly!

[biosectinvestor]

Because they want to avoid a fraud lawsuit... not because of the 4 day rule, or the 8K requirement. It’s good practice. But companies also do not always agree what “bad results” are in fact. So they have time to review data.

Those statements are not the same thing.

[biosectinvestor]

You engage in bad logic and generalities to make yourselves think you’re saying something real. Law is more layered and complicated and while good practice is how you advice your non-lawyer CEO, if they have reason to need time to review data, a lawyer will work with them to figure out the best way to do that also.

Hiding data is something different. No lawyer would advise to “hide” data.

[Poor Man -]

Right, there is absolutely no way a biotech cannot disclose a material event — in the form of a failed trial, not meeting its end point — within a short period of time.

Immediately is immediately, forget about four days. I’ll say it again, a biotech and its management are walking a legal minefield by waiting to report a failed trial, ASAP.

What are the odds that NWBO has not yet received TLD? What are the odds that option valuations require additional attention w/o TLD as a trigger?

[Kam8]

Absolutely amazing post. Cheers